Innovent Biologics, Inc. (HKG:1801)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
85.20
-1.70 (-1.96%)
Oct 22, 2025, 2:45 PM HKT

Innovent Biologics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
148,83859,95669,33351,40370,547115,098
Upgrade
Market Cap Growth
95.82%-13.53%34.88%-27.14%-38.71%243.36%
Upgrade
Enterprise Value
142,08754,28363,85044,89959,352109,367
Upgrade
Last Close Price
86.9036.6042.7533.5048.2582.05
Upgrade
PS Ratio
11.895.9810.149.9813.4625.21
Upgrade
PB Ratio
9.424.305.024.245.5611.04
Upgrade
P/TBV Ratio
10.424.405.044.255.5711.04
Upgrade
P/FCF Ratio
93.82175.32----
Upgrade
P/OCF Ratio
74.7843.78425.78---
Upgrade
EV/Sales Ratio
11.355.419.348.7211.3323.96
Upgrade
EV/EBITDA Ratio
102.572126.28----
Upgrade
EV/FCF Ratio
89.57158.73----
Upgrade
Debt / Equity Ratio
0.230.220.290.300.240.14
Upgrade
Debt / EBITDA Ratio
2.5450.93----
Upgrade
Debt / FCF Ratio
2.338.81----
Upgrade
Asset Turnover
0.520.450.330.270.300.40
Upgrade
Inventory Turnover
2.942.691.511.001.191.45
Upgrade
Quick Ratio
2.252.082.682.783.275.85
Upgrade
Current Ratio
2.612.353.003.293.796.37
Upgrade
Return on Equity (ROE)
8.43%-0.74%-8.84%-20.70%-28.56%-14.75%
Upgrade
Return on Assets (ROA)
2.65%-0.82%-5.12%-11.54%-12.04%-3.65%
Upgrade
Return on Capital (ROIC)
3.46%-1.08%-6.49%-14.57%-14.81%-4.46%
Upgrade
Earnings Yield
0.83%-0.17%-1.63%-4.79%-4.75%-1.03%
Upgrade
FCF Yield
1.07%0.57%-1.54%-6.19%-5.38%-0.82%
Upgrade
Buyback Yield / Dilution
-3.74%-4.35%-4.67%-2.37%-7.27%-15.23%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.